These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33445171)

  • 1. Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report.
    Drelles K; Pilarski R; Manickam K; Shoben AB; Toland AE
    Public Health Genomics; 2021; 24(1-2):26-32. PubMed ID: 33445171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
    McGrath SP; Walton N; Williams MS; Kim KK; Bastola K
    BMC Health Serv Res; 2019 Nov; 19(1):844. PubMed ID: 31760949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.
    Bloss CS; Schork NJ; Topol EJ
    J Med Genet; 2014 Feb; 51(2):83-9. PubMed ID: 24343916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
    Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public perspectives about pharmacogenetic testing and managing ancillary findings.
    Haga SB; Tindall G; O'Daniel JM
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):193-7. PubMed ID: 22047505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
    Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
    Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.
    Haga SB; Mills R; Bosworth H
    Patient Educ Couns; 2014 Oct; 97(1):10-5. PubMed ID: 24985359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.
    Mowbray C; Turner J; Gai J; Jacobs S
    J Pediatr Hematol Oncol Nurs; 2022; 39(3):168-177. PubMed ID: 35467433
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing uptake of pharmacogenetic testing in a diverse patient population.
    O'Daniel J; Lucas J; Deverka P; Ermentrout D; Silvey G; Lobach DF; Haga SB
    Public Health Genomics; 2010; 13(1):48-54. PubMed ID: 19407441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
    Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
    Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
    Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A
    Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of US public attitudes toward pharmacogenetic testing.
    Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
    Pharmacogenomics J; 2012 Jun; 12(3):197-204. PubMed ID: 21321582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use.
    Sloat NT; Yashar BM; Ellingrod VL; Ward KM
    J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of pharmacogenetic testing into medication therapy management.
    Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
    Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy.
    Zhang L; Zhou S; Allen JD; Wang F; Pittenger AL; Bishop JR
    Clin Transl Sci; 2023 Nov; 16(11):2356-2368. PubMed ID: 37721333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.
    Carere DA; VanderWeele TJ; Vassy JL; van der Wouden CH; Roberts JS; Kraft P; Green RC
    Genet Med; 2017 May; 19(5):537-545. PubMed ID: 27657683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.